European Journal of Clinical Pharmacology

, Volume 3, Issue 4, pp 189–193 | Cite as

Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults

  • M. Ehrnebo
  • S. Agurell
  • B. Jalling
  • L. O. Boréus
Originals

Summary

The binding to human plasma proteins of ampicillin, α-azidobenzylpenicillin, benzylpenicillin, phenobarbital and diphenylhydantoin was studied by equilibrium dialysis of labelled compounds. Human foetal and neonatal plasma had very low binding capacities for all five drugs as compared with plasma from adults. Hyperbilirubinemia in the neonatal period further decreased the binding capacity. The age dependence of drug binding activity should be taken into account when analysing pharmacological effects in foetuses and newborn children.

Key-words

Protein binding foetus infant newborn antibiotics anticonvulsants 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Boréus, L.O.: Placental transfer of ampicillin. To be published in Acta Pharmacol. Toxicol. 1971.Google Scholar
  2. 2.
    Ganshorn, A., Kurz, H.: Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung. Naunyn-Schmiedebergs Arch. Pharmak.260, 117–118 (1968).Google Scholar
  3. 3.
    Gornall, A.G., Bardawill, J. David, M.M.: Determination of serum proteins by means of the biuret reaction. J. biol. Chem.177, 751–766 (1949).Google Scholar
  4. 4.
    Grunbaum, B.W., Zec, J., Durrum, E.L.: Application of an improved microelectrophoresis technique and immunoelectrophoresis of the serum proteins on cellulose acetate. Microchem. J.7, 41–53 (1963).Google Scholar
  5. 5.
    Jalling, B., Boréus, L.O., Rane, A., Sjöqvist, F.: Plasma concentrations of diphenylhydantoin in young infants. Pharmacol. Clin. (Berl.)2, 198–200 (1970).Google Scholar
  6. 6.
    Keen, P.M.: The binding of penicillins to bovine serum albumin. Biochem. Pharmacol15, 447–463 (1966).Google Scholar
  7. 7.
    Lous, P.: Plasma levels and urinary excretion of three barbituric acids after oral administration to man. Acta pharmacol. (Købh.)10, 147–165 (1954).Google Scholar
  8. 8.
    Lunde, P.K.M., Rane, A., Yaffe, S.J., Lund, L., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man: Interaction with other drugs and the effect of temperature and plasma dilution. Clin. Pharmacol. Ther.11, 846–855 (1970).Google Scholar
  9. 9.
    Nosslin, B.: The direct diazo reaction of bile pigments in serum. Scand. J. clin. Lab. Invest.12, Suppl. 49 (1960).Google Scholar
  10. 10.
    Rane, A., Lunde, P.K.M., Jalling, B., Yaffe, S.J., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in normal and hyperbilirubinemic infants. J. Pediat.78, 877–882 (1971).Google Scholar
  11. 11.
    Scholtan, W.: Die Bindung der Penicilline an die Eiweißkörper des Plasmas und der Gewebsflüssigkeit. Antibiot. Chemother. (Basel)14, 55–93 (1968).Google Scholar
  12. 12.
    Sjöberg, B., Ekström, B., Forsgren, U.: α-Azidobenzylpenicillin. I. Chemistry, bacteriology, and experimental chemotherapy. Antimicrob. Agents Chemother. 1967, 560 – 567.Google Scholar
  13. 13.
    Svensmark, O., Buchtal, F.: Dosage of phenytoin and phenobarbital in children. Dan. med. Bull.10, 234–235 (1963).Google Scholar
  14. 14.
    Thalme, B.: A system of microliter methods suitable for routine clinical work. Acta med. scand.174, Suppl. 403, 1–16 (1963).Google Scholar
  15. 15.
    Warren, G.H.: The prognostic significance of penicillin serum levels and protein binding in clinical medicine. A review of current studies. Chemotherapia (Basel)10, 339–358 (1965/66).Google Scholar

Copyright information

© Springer-Verlag 1971

Authors and Affiliations

  • M. Ehrnebo
    • 1
  • S. Agurell
    • 1
  • B. Jalling
    • 1
  • L. O. Boréus
    • 1
  1. 1.Central Military Pharmacy and Department of Clinical PharmacologyKarolinska HospitalStockholmSweden

Personalised recommendations